On the Czech market as Teva Pharmaceuticals CR, sro since 1997, part of the global pharmaceutical corporation Teva Pharmaceutical Industries Ltd., dating its history back to 1901 in Israel.
With an annual turnover of over 2 billion (2014), Teva has a strong second place in the Czech generic market, and is ranking number six in the overall pharmaceutical ranking. We have a product portfolio of more than 220 drugs. Based in Prague, Teva annually delivers more than 19 million packages of drugs.
In the area of OTC medicines, Teva Pharmaceuticals CR, sro has a significant market position through familiar brands such as Vicks, Vibovit, Stoptussin and more.
Contact
Address: Sokolovska 651/136A, 180 00 Praha 8, Czech Republic
Tel: +420 251 007 101
Web: http://www.teva.cz/
Mr. Zahradnik, you have long been an active member of the Czech generic drug makers’ association CAFF (Czech Association of Pharmaceutical Firms), chairing the organization. Dr. Zörner, executive director of…
Mr. Kotek, can you please begin by introducing us to the SVOPL and telling us what the mission is here in the Czech Republic? We are a relatively new Association…
Mr. Dvořáček, in 2010, the AIFP commissioned a study on the economic footprint of the innovative pharmaceutical industry in the Czech Republic. Can you begin by expounding the results of…
See our Cookie Privacy Policy Here
